Differences in tolerability of pirfenidone between elderly and younger patients with idiopathic pulmonary fibrosis

PURPOSE: Although pirfenidone (PFD) is a key drug for the treatment of idiopathic pulmonary fibrosis (IPF), differences in tolerability between elderly and young patients remain unclear. This study aimed to investigate age-related differences in adverse drug reactions to PFD and to evaluate whether...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakayori, Masashi, Terada, Jiro, Abe, Mitsuhiro, Hirasawa, Yasutaka, Suzuki, Kenichi, Yoshioka, Keiichiro, Tsushima, Kenji, Tatsumi, Koichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630358/
https://www.ncbi.nlm.nih.gov/pubmed/31371923
http://dx.doi.org/10.2147/DDDT.S208733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630358/
https://www.ncbi.nlm.nih.gov/pubmed/31371923
http://dx.doi.org/10.2147/DDDT.S208733

Ejemplares similares